Colgate-Palmolive Company (NYSE:CL) – Stock analysts at KeyCorp raised their FY2017 earnings per share estimates for shares of Colgate-Palmolive in a research report issued on Monday. KeyCorp analyst J. Gere now forecasts that the company will earn $2.89 per share for the year, up from their prior estimate of $2.88. KeyCorp currently has a “Hold” rating on the stock.
Other equities research analysts have also issued research reports about the company. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price target on the stock in a research report on Monday, September 25th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Sunday, October 8th. BidaskClub lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Deutsche Bank AG reaffirmed a “hold” rating and issued a $75.00 price target on shares of Colgate-Palmolive in a research report on Monday, July 24th. Finally, Wells Fargo & Company reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $76.85.
COPYRIGHT VIOLATION NOTICE: “KeyCorp Research Analysts Increase Earnings Estimates for Colgate-Palmolive Company (CL)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/28/keycorp-research-analysts-increase-earnings-estimates-for-colgate-palmolive-company-cl.html.
Colgate-Palmolive (NYSE:CL) traded down 1.30% during trading on Wednesday, reaching $73.47. The company’s stock had a trading volume of 963,150 shares. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27. The stock has a market capitalization of $64.72 billion, a PE ratio of 27.30 and a beta of 0.81. The stock has a 50 day moving average price of $72.75 and a 200 day moving average price of $73.23.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same quarter in the previous year, the firm earned $0.70 earnings per share. The firm’s quarterly revenue was down .5% compared to the same quarter last year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Monday, October 23rd will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.15%. Colgate-Palmolive’s dividend payout ratio is presently 59.48%.
In related news, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total transaction of $999,040.00. Following the transaction, the senior vice president now owns 88,598 shares in the company, valued at approximately $6,322,353.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $71.45, for a total value of $273,867.85. Following the transaction, the insider now owns 53,173 shares in the company, valued at approximately $3,799,210.85. The disclosure for this sale can be found here. Insiders have sold a total of 214,136 shares of company stock worth $15,416,385 in the last 90 days. 1.02% of the stock is currently owned by company insiders.
Large investors have recently added to or reduced their stakes in the stock. American Beacon Advisors Inc. purchased a new position in Colgate-Palmolive during the 1st quarter worth approximately $102,000. Proficio Capital Partners LLC grew its stake in Colgate-Palmolive by 16.9% during the 1st quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after buying an additional 207 shares during the last quarter. OLD Second National Bank of Aurora purchased a new position in Colgate-Palmolive during the 2nd quarter worth approximately $109,000. Krilogy Financial LLC grew its stake in Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares during the last quarter. Finally, Hanson & Doremus Investment Management grew its stake in Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after buying an additional 70 shares during the last quarter. Hedge funds and other institutional investors own 73.09% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.